Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

per Regnault, Antoine, Boroojerdi, Babak, Meunier, Juliette, Bani, Massimo, Morel, Thomas, Cano, Stefan
Publicat a J Neurol (2019)

Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder

per Furmark, Tomas, Henningsson, Susanne, Appel, Lieuwe, Åhs, Fredrik, Linnman, Clas, Pissiota, Anna, Faria, Vanda, Oreland, Lars, Bani, Massimo, Pich, Emilio Merlo, Eriksson, Elias, Fredrikson, Mats
Publicat 2009

Amygdala Subregions Tied to SSRI and Placebo Response in Patients with Social Anxiety Disorder

per Faria, Vanda, Appel, Lieuwe, Åhs, Fredrik, Linnman, Clas, Pissiota, Anna, Frans, Örjan, Bani, Massimo, Bettica, Paolo, Pich, Emilio M, Jacobsson, Eva, Wahlstedt, Kurt, Fredrikson, Mats, Furmark, Tomas
Publicat 2012

Occupancy of Brain Dopamine D(3) Receptors and Drug Craving: A Translational Approach

per Mugnaini, Manolo, Iavarone, Laura, Cavallini, Palmina, Griffante, Cristiana, Oliosi, Beatrice, Savoia, Chiara, Beaver, John, Rabiner, Eugenii A, Micheli, Fabrizio, Heidbreder, Christian, Andorn, Anne, Merlo Pich, Emilio, Bani, Massimo
Publicat 2013

In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism

per Erritzoe, David, Tziortzi, Andri, Bargiela, David, Colasanti, Alessandro, Searle, Graham E, Gunn, Roger N, Beaver, John D, Waldman, Adam, Nutt, David J, Bani, Massimo, Merlo-Pich, Emilio, Rabiner, Eugenii A, Lingford-Hughes, Anne
Publicat 2014

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

per Conrado, Daniela J., Nicholas, Timothy, Tsai, Kuenhi, Macha, Sreeraj, Sinha, Vikram, Stone, Julie, Corrigan, Brian, Bani, Massimo, Muglia, Pierandrea, Watson, Ian A., Kern, Volker D., Sheveleva, Elena, Marek, Kenneth, Stephenson, Diane T., Romero, Klaus
Publicat a Clin Transl Sci (2017)

A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: a Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial

per Mathew, Sanjay J., Vythilingam, Meena, Murrough, James W., Zarate, Carlos A., Feder, Adriana, Luckenbaugh, David A., Kinkead, Becky, Parides, Michael K., Trist, David G., Bani, Massimo S., Bettica, Paolo U., Ratti, Emiliangelo M., Charney, Dennis S.
Publicat 2010

A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety

per Furmark, Tomas, Appel, Lieuwe, Henningsson, Susanne, Åhs, Fredrik, Faria, Vanda, Linnman, Clas, Pissiota, Anna, Frans, Örjan, Bani, Massimo, Bettica, Paolo, Pich, Emilio Merlo, Jacobsson, Eva, Wahlstedt, Kurt, Oreland, Lars, Långström, Bengt, Eriksson, Elias, Fredrikson, Mats
Publicat a J Neurosci (2008)

Development of a disease progression model for leucine-rich repeat kinase 2 in Parkinson’s disease to inform clinical trial designs

per Ahamadi, Malidi, Conrado, Daniela J, Macha, Sreeraj, Sinha, Vikram, Stone, Julie, Burton, Jackson, Nicholas, Timothy, Gallagher, Jill, Dexter, David, Bani, Massimo, Boroojerdi, Babak, Smit, Hans, Weidemann, Jonas, Chen, Chao, Yang, Minhua, Maciuca, Romeo, Lawson, Rachael, Burn, David, Marek, Kenneth, Venuto, Charles, Stafford, Bob, Akalu, Mussie, Stephenson, Diane, Romero, Klaus
Publicat a Clin Pharmacol Ther (2019)